Karlin Dan's Form 4 filing
Definium Therapeutics, Inc. (DFTX) · filed Dec 29, 2025
- Accession no.
- 0001193125-25-335484
- Filed
- Dec 29, 2025
- Trade date
- Dec 26, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $73.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Karlin DanCIK 0001897618 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | Common Shares | SSaleDisposed | −5,600 | $13.15 | −$73,640 | 425,025 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.